Neurotoxicity of glutamate uptake inhibition in vivo: Correlation with succinate dehydrogenase activity and prevention by energy substrates

Neuroscience

Volumn 106, Issue 4, 2001, Pages 669-677

  Massieu, L ^a   Del Rio P ^a   Montiel, T ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

3 nitropropionic acid; Acetoacetate; Creatine; Glutamate transport; Pyruvate

Indexed keywords

2,4 PYRROLIDINEDICARBOXYLIC ACID; 3 HYDROXYBUTYRIC ACID; 3 NITROPROPIONIC ACID; ACETOACETIC ACID; ASPARTIC ACID; CREATININE; DIZOCILPINE; ENZYME INHIBITOR; GLUTAMIC ACID; KETONE BODY; NEUROPROTECTIVE AGENT; PYRUVIC ACID; SUCCINATE DEHYDROGENASE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONOLOGY; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION FUNCTION; ENERGY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VIVO STUDY; INJECTION; MALE; MITOCHONDRION; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

3-HYDROXYBUTYRIC ACID; ACETOACETATES; AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; BRAIN ISCHEMIA; CONVULSANTS; CREATINE; DICARBOXYLIC ACIDS; DRUG INTERACTIONS; ENERGY METABOLISM; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MALE; NEOSTRIATUM; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NEUROTRANSMITTER UPTAKE INHIBITORS; NITRO COMPOUNDS; PROPIONIC ACIDS; PYRROLIDINES; PYRUVIC ACID; RATS; RATS, WISTAR; SUCCINATE DEHYDROGENASE;

EID: 0035980445     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00323-2     Document Type: Article

References (55)

1. 3-Nitropropionate, the substance of Indigofera, is a suicide inactivator of succinate dehydrogenase
2. Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient flobal ischemia in the rabbit brain
3. The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures
4. Protective effect of the energy precursor creatine against toxicity of glutamate and β-amyloid in rat hippocampal neurons
5. Conformationally defined neurotransmitter analogs. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer
6. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat
7. On the mechanisms of neuroprotection by creatine and phosphocreatine
8. Oxidative stress, glutamate and neurodegenerative disorders
9. Ketone bodies and brain glutamate and GABA metabolism
10. Pyruvate protects neurons against hydrogen peroxide-induced toxicity
11. 2+ exchanger
12. 2+ after toxic NMDA-receptor activity
13. The role of excitatory amino acids and NMDA receptors in traumatic brain injury
14. Strategies of neuroprotection against L-trans-2,4-pyrrolidine dicarboxylate-induced neuronal damage during energy impairment in vitro
15. Effect of ischemia on the release of striatal dopamine, glutamate, and γ-aminobutyric acid studied by intracerebral microdialysis
16. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage
17. The role of neuronal energy in the neurotoxicity of excitatory amino acids
18. Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: Reversal by lactate and pyruvate
19. Metabolic control of kynurenic acid formation in the rat brain
20. Excitotoxicity and neurodegenerative diseases
21. Effects of lactate and pyruvate on glucose deprivation in rat hippocampal slices
22. Endogenous monocarboxylates sustain hippocampal synaptic function and morphological integrity during energy deprivation
23. β-Hydroxybutyrate fuels synaptic function during development
24. D-β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
25. Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid
26. Neuroprotective effects of creatine administration against NMDA and malonate toxicity
27. Glutamate uptake impairment and neuronal damage in young and aged rats in vivo
28. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: An in vivo microdialysis study
29. In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate
30. Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia
31. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
32. Pyruvate and lactate protect striatal neurons against N-methyl-D-aspartate-induced neurotoxicity
33. Glucose and ketone body utilization by the brain of neonatal rats
34. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced
35. Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy
36. Extracellular neuroactive amino acids in the rat striatum during ischemia: Comparison between penumbral conditions and ischemia with sustained anoxic depolarisation
37. The role of creatine kinase in inhibition of mitochondrial permeability transition
38. Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model
39. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: Acute excitotoxic necrosis and delayed apoptosis
40. Starvation-induced changes in transport of ketone bodies across the blood-brain barrier
41. Glutamate release in severe brain ischaemia is mainly by reversed uptake
42. Protection by pyruvate and malate against glutamate-mediated neurotoxicity
43. Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired
44. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: In vivo dialysis of the rat hippocampus
45. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity
46. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases
47. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity
48. Preclinical studies of glutamate receptor antagonists for the treatment of cerebral ischemia
49. The competitive transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition
50. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The 'phosphocreatine circuit' for cellular energy homeostasis
51. Extracellular glutamate during focal cerebral ischaemia in rats: Time course and calcium dependency
52. Effect of phosphomonoesters, phosphodiesters, and phosphocreatine on glutamate uptake by synaptic vesicles
53. Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina
54. 2+ block at the N-methyl-D-aspartate receptor underlines receptor activation during inhibition of neuronal metabolism